tm
Seeing Is Believing
tm
Seeing Is Believing
CTNM is currently covered by 1 analysts with an average price target of $21.56. This is a potential upside of $17.63 (448.6%) from yesterday's end of day stock price of $3.93.
Contineum Therapeutics, Common Stock's activity chart (see below) currently has 0 price targets and 4 ratings on display. The stock rating distribution of CTNM is 100% BUY.
Highest price target for CTNM is $31, Lowest price target is $31, average price target is $31.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 08-Jan-2025. First documented stock forecast 30-Apr-2024.
Currently out of the existing stock ratings of CTNM, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$31
$26.57 (599.77%)
$31
5 months 9 days ago
(08-Jan-2025)
0/4 (0%)
$17.63 (131.86%)
What is CTNM (Contineum Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on CTNM (Contineum Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on CTNM (Contineum Therapeutics, Common Stock)?
Which analyst is the currently most bullish on CTNM (Contineum Therapeutics, Common Stock)?
